Document is current
Any future updates will be listed below
-
Authors
Devi, K. Sanjana P.
Wang, Eric https://orcid.org/0009-0005-9564-2990
Jaiswal, Abhinav
Konieczny, Piotr https://orcid.org/0000-0003-4114-349X
Kim, Tae-Gyun
Nirschl, Christopher J. https://orcid.org/0000-0002-7333-2757
Verma, Akanksha
Liu, Yong https://orcid.org/0000-0002-0196-3285
Milczanowski, Julia
Christo, Susan N.
Gandolfo, Luke C. https://orcid.org/0000-0002-3599-2455
Haitz, Karyn
Vardam, Trupti D. https://orcid.org/0000-0003-1458-1902
Wu, Pinru
King, Sandra L. https://orcid.org/0000-0001-9367-5354
Tse, Sze-Wah
Pradhan, Komal
Jiang, Xiaodong
Tian, Tian
Fuhlbrigge, Robert C. https://orcid.org/0000-0002-0911-9310
Schmults, Chrysalyne D.
Clark, Rachael A.
Kupper, Thomas S. https://orcid.org/0000-0002-4229-2916
Freeman, Gordon J. https://orcid.org/0000-0002-7210-5616
Mackay, Laura K. https://orcid.org/0000-0002-8496-6632
Naik, Shruti https://orcid.org/0000-0002-2216-5135
Newell, Evan W.
Elemento, Olivier https://orcid.org/0000-0002-8061-9617
Suarez-Farinas, Mayte https://orcid.org/0000-0001-8712-3553
Anandasabapathy, Niroshana https://orcid.org/0000-0002-0473-8358
- License Information
-
More Information
Article History
Received: 12 April 2023
Accepted: 16 June 2025
First Online: 29 July 2025
Competing interests
: G.J.F. has patents/pending royalties on the PD-1/PD-L1 pathway from Roche, Merck MSD, Bristol-Myers-Squibb, Merck KGA, Boehringer-Ingelheim, AstraZeneca, Dako, Leica, Mayo Clinic and Novartis. G.J.F. has served on advisory boards for Roche, Bristol-Myers-Squibb, Xios, Origimed, Triursus, iTeos, NextPoint, IgM, Jubilant, Trillium and GV20. G.J.F. has equity in Nextpoint, Triursus, Xios, iTeos, IgM and GV20. S.N. is cofounder of Stara Biosciences and serves on the scientific advisory board of Seed. E.W.N. is a cofounder, advisor and shareholder of ImmunoScape and is an advisor for Neo-gene Therapeutics. C.J.N. is an employee and shareholder of Werewolf Therapeutics. M.S.-F. has been a consultant for Symbrio, SpectralMD and DBV. R.A.C. is on the scientific advisory board for AAAS, Almirall and Sedec Therapeutics. N.A. serves on the scientific advisory board of Shennon Biosciences and Panther Life Sciences and is a consultant or lecturer for Johnson and Johnson, Immunitas, 3T, 23andme, Cellino, Kumquat, Verrica, Lytix, Network Bio and Genmab. The other authors have no conflicts to declare.
